Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

The effects of proxazole on renal function in chronic renal failure

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Wainer, E.
  • Wittenberg, Curt
  • Boner, G.
  • Rosenfeld, J. B.

publication date

  • 1981

journal

  • Arzneimittel-Forschung  Journal

abstract

  • 3-alpha-Phenyl-propyl-5-beta-diethylaminoethyl-1,2,3-oxadiazole (proxazole), a spasmolytic papaverine-like agent, was i.v. administered to 13 patients with chronic renal failure (mean creatinine clearance 46.4 ml/min/1.73 m2), but did not improve renal plasma flow (p-aminohippurate clearance) or glomerular filtration rate (inulin clearance), nor did this agent prevent or modify nor-adrenaline induced renal ischemia. The oral administration of 400 mg proxazole (5.2--6.5 mg/kg/day) for a period of at least 90 days did not improve renal function in 11 patients with chronic renal failure. It is concluded that both i.v. and p.o. administration of proxazole in the dosages used is ineffective in improving renal function in patients with chronic renal failure.

subject areas

  • Administration, Oral
  • Aged
  • Benzyl Compounds
  • Blood Pressure
  • Female
  • Humans
  • Injections, Intravenous
  • Kidney
  • Kidney Failure, Chronic
  • Male
  • Middle Aged
  • Oxadiazoles
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0004-4172

PubMed ID

  • 7194677
scroll to property group menus

Additional Document Info

start page

  • 527

end page

  • 528

volume

  • 31

issue

  • 3

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support